JADAK’s Post

🚨 The Volpi Voice is here! 🚨 The newest edition of The Volpi Voice is here, brimming with impactful stories and updates. 🎉 Volpi’s 70-Year Celebration and Beyond 🎉 Join us as we commemorate 70 years of dedicated service! Get a glimpse of our vision for the coming years as we continue pushing the boundaries of diagnostic technology. 🔬 Revolutionizing #IVD: #Multimodal Platforms at the Point of Care 🔬 Explore how multimodal IVD platforms are transforming diagnostics at the point of care. We take you behind the scenes to learn about the latest advances and the real-world impact of integrated diagnostics. 🧬 Multi-Omics: Precision Medicine in Action 🧬 See how multi-omics is redefining healthcare by integrating diverse biological data, paving the way for personalized medicine and early disease detection. 👨🔬 Meet Volpi's Head of R&D, Francisco Faoro 👨🔬 Gain an insider’s view into the world of R&D at Volpi with Francisco Faoro. Discover how our R&D team brings complex concepts to life and develops solutions that address critical medical needs. Catch up on the latest from Volpi and join the conversation on the future of diagnostics. Read The Volpi Voice now! #volpigroup #lightinsightlife #thevolpivoice #ivd #multimodalplatforms #multiomics #pointofcare https://lnkd.in/ebVJGPid

Discover the latest issue of The Volpi Voice! This edition highlights the integration of #multimodal platforms for #invitrodiagnostics at the point of care, as well as an introduction to #multiomics for #precisionmedicine. Get your copy of The Volpi Voice today!" #POCT #genomics #proteomics #transcriptomics #metabolomics #

Following the conclusion of the ASLM Diagnostics Convention 2024, watch as our CEO, Mr. Nqobile Ndlovu, shares the driving factors behind hosting the conference and emphasizes the importance of shining a light on diagnostics and raising awareness of the role of laboratory medicine. #ASLMDiagnosticsConvention2024

I can’t wait to connect and collaborate at BIO 2024. Especially eager to discuss pain points in clinical development pipelines. You can contact me by email. Or request a meeting via the BIO partnering system: https://lnkd.in/gzSnamDw Want to hear how autoantibodies can enable precision medicine? Oncimmune’s CEO Martin Gouldstone and other panel members will be discussing just that: https://lnkd.in/gtN_cV_7 #BIO2024 #Oncimmune #autoantibodies #precisionmedicine

Attending #ACS2024? Don’t miss the opportunity to check out poster #21 from our very own Kevin Lo, Ph.D., SCYM(ASCPi)CM! The poster presents the use of Lyophilized Beads as a robust and cost-efficient way for generating consistent flow cytometry data across different geographical locations. This research represents a valuable tool in conducting successful global clinical trials. 🌏 Schedule a meeting with our team to learn more: 👉 https://bit.ly/3KOO1m3 #FlowCytometry #PrecisionMedicine

Join our #DPHARM2024 session on Tuesday, Sept 17th @ 3:30 PM as we take the stage to share how Avillion Life Sciences leveraged Science 37's Virtual Site to successfully deliver a pivotal study. Hear firsthand how our collaboration, adaptability, and shared insights led to remarkable outcomes. Don't miss this opportunity to learn from the experts! 🎤 Brian Smith 🎤 Tracy Killingsworth, RRT DPHARM: Disruptive Innovations to Modernize Clinical Research #clinicalresearch #clinicaltrials #clinicalstudies

Register for this webinar to learn how configurable solutions are transforming study launches by reducing coding errors, enhancing consistency across studies and enabling the acquisition of more reliable data. This not only streamlines the process but also makes it more cost-effective compared to traditional customized solutions that require complex and lengthy implementations.

Thank you for meeting with us at the APM Annual Conference 2024 in Philadelphia! Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, delivered her talk on, “How Can We Close the Clinical Practice Gaps in Precision Medicine?” This talk built on insights from Diaceutics’ globally recognized Practice Gaps paper, published in JCO in 2022, which revealed that 64% of aNSCLC patients do not receiving the most appropriate drug for their genetic profile. Susanne discussed how these gaps have evolved, and shared insights into the operational, economic, and policy challenges that continue to impact precision medicine, as well as outlined the current state of the industry, highlighting actionable steps we can take to collaboratively close these gaps. If you attended, we hope you had a chance to connect with our team and pick up your copy of the Recommendations paper! For more information, and to download the Recommendations paper, click the link below: https://lnkd.in/e7FnGF49 #PrecisionMedicine #BetterTestingBetterTreatment

Great to see Steph Eaneff showcasing the process we use to learn and develop our products in this poster presented at @DTx West. By iterating on clinical studies, testing new concepts, and generating new hypotheses to validate in future studies, we’re creating the dynamic cycle that keeps Woebot well ahead. #dtx #digitaltherapeutics #digitalhealth #digitalhealthinnovation

The transformation of healthcare and the drive to enhance patient care can only be achieved through strong partnerships. The shared mission of Velatura Public Benefit Corporation & Spesana is changing the continuum of care for clinicians and patients. Improved prior authorization means faster time to diagnosis and faster time to treatment. #partnerships  #precisionmedicine  #priorauthorization  #healthcare #transformation  #hie #interoperability  #patientcare  #moleculardiagnostics